002864 盘龙药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)5.4117.5548.91111.75612.323
总资产报酬率 ROA (%)3.8375.4615.4466.2057.475
投入资产回报率 ROIC (%)4.9486.9767.3789.02511.006

边际利润分析
销售毛利率 (%)52.68560.82557.91958.12358.278
营业利润率 (%)12.82814.20813.75012.62712.679
息税前利润/营业总收入 (%)11.17411.66811.56311.91211.375
净利润/营业总收入 (%)10.64912.31411.37310.58710.654

收益指标分析
经营活动净收益/利润总额(%)99.53695.001103.655104.739106.234
价值变动净收益/利润总额(%)-0.1630.461-1.204-0.0950.000
营业外收支净额/利润总额(%)-1.153-1.033-4.341-3.224-3.206

偿债能力分析
流动比率 (X)3.1083.9713.4921.6422.186
速动比率 (X)2.9123.7573.3311.5372.033
资产负债率 (%)29.79228.19427.00050.92139.316
带息债务/全部投入资本 (%)2.3633.2150.88526.4707.588
股东权益/带息债务 (%)3,875.3202,839.64110,562.201262.7601,152.300
股东权益/负债合计 (%)235.415254.374269.98194.555151.326
利息保障倍数 (X)-7.411-4.872-7.162-37.118-12.501

营运能力分析
应收账款周转天数 (天)128.160138.994151.879148.706138.304
存货周转天数 (天)72.42181.72175.12171.20164.731